CTU1 promotes cancer resistance to targeted therapy [41], its expression is associated with higher rates of morbidity and mortality in spinal cord gliomas [42], and up-regulation of CTU1 is involved in human breast cancer metastasis. This evidence concerns the gene CTU1 and cancer.